Effect of HIgh-Flow Therapy in Long-Term Oxygen Therapy (HILOT): study protocol for a multicentre, registry-based, randomised clinical trial
Authors:
- Josefin SundhJSJosefin Sundh
- Anders BlombergABAnders Blomberg
- Pia GhoshPGPia Ghosh
- Taivo KipperTKTaivo Kipper
- Ozran KrickaOKOzran Kricka
Open Access
- 4 February 2026
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 27 (1)
Abstract
Background: The use of high-flow oxygen therapy (HFOT) compared with standard low-flow oxygen therapy (LFOT) may improve outcomes in people with oxygen-dependent chronic respiratory failure (CRF). The primary aim of this multicentre trial was to evaluate HFOT in addition to LFOT, compared with regular LFOT in people with CRF due to chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD). Methods: Registry-based randomised controlled trial (R-RCT) of people on LFOT for CRF due to COPD ( n = 270) and ILD ( n = 40), at ten Swedish secondary care centres within the Swedish Register for Respiratory Failure (Swedevox). People with ongoing LFOT are randomised in a 1:1 ratio to standard treatment with LFOT (control) or LFOT with added HFOT during nighttime and at the patient’s discretion daytime (intervention). HFOT is provided using the ResMed Lumis HFT system and the AcuCare HFNC Cannula. Primary outcome is time to first hospitalisation or death up to 1 year in people with COPD. Secondary outcomes include symptoms, health-related outcomes (HRQL), health-economics, adverse events, and to explore the effects of HFOT in people with CRF due to ILD. Outcome data will be obtained from national registries and from patient questionnaires at 3 and 12 months. Discussion: This R-RCT will combine the advantages of a prospective randomised trial and large clinical national registries to improve the evidence-based use of long-term oxygen therapy. Recruitment started in June 2024 and is ongoing. Trial registration: ClinicalTrials.gov, ID: NCT06247397. Registered 2024–02–07.Keywords
Funding Information
- Vetenskapsrådet (2019-02081)
- Svenska Läkaresällskapet (SLS-985470)
- Örebro University
This publication has 40 references indexed in Scilit:
- Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe HypoxemiaNew England Journal of Medicine, 2024
- Risk and outcomes of COVID-19 in patients with oxygen-dependent chronic respiratory failure– a national cohort studyRespiratory Medicine, 2023
- Validation of the Dyspnea Exertion Scale of Breathlessness in People With Life-Limiting IllnessJournal of Pain and Symptom Management, 2018
- Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in High-Risk PatientsJAMA, 2016
- Effects of heated and humidified high flow gases during high-intensity constant-load exercise on severe COPD patients with ventilatory limitationRespiratory Medicine, 2016
- High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic SurgeryJAMA, 2015
- Sample size formula for proportional hazards modelling of competing risksStatistics in Medicine, 2004
- BronchiectasisNew England Journal of Medicine, 2002
- Relationship between the humidity and temperature of inspired gas and the function of the airway mucosaCritical Care Medicine, 1996
- Domestic activities and walking in the elderly: Evaluation from a 30- hour heart rate recordingAging Clinical and Experimental Research, 1990